FOR SPONSORS AND CROs

Site Startup Shouldn’t Take
Longer Than the Study.

BNZ replaces dozens of parallel site negotiations with a single point of contact — 24–48 hour feasibility, favorable per-site budgets, and centralized oversight across 120+ pre-vetted US sites.

120+

Pre-Vetted US Sites

24–48h

Feasibility Turnaround

I–IV

Trial Phases

1

Point of Contact

Multi-Site Startup, Simplified

THE OLD WAY

Dozens of individual site outreach emails, each with its own timeline and terms.
Feasibility responses trickle in over days or weeks, with no consistent format.
Every site negotiates its own budget with your team, on its own schedule.
Site accountability and compliance tracked separately, site by site.
Status updates come from wherever you can get them.

THE BNZ WAY

One point of contact for outreach, feasibility, and every site in the network.
Structured feasibility returned within 24–48 hours.
BNZ negotiates favorable per-site budgets directly — you approve, not chase.
Every site operates under a defined Site Collaboration Agreement, monitored centrally.
Regular status updates and immediate escalation from a dedicated team.

From Protocol to Activation

Feasibility & Match

Share your protocol synopsis. We assess it against the network and return initial feasibility within 24–48 hours — matched by enrollment history, expertise, and geography.

Contract & Budget

BNZ negotiates favorable, transparent budgets with every participating site individually, while staying your single point of contact for every contract and budget conversation.

Startup & Activation

Once terms are set, we drive the full startup process — coordinating site visits, documentation, and timelines to get every study moving quickly.

Ongoing Oversight

From first patient in to close-out, our team provides regular status updates, a consistent point of contact for each site, and immediate escalation the moment an issue arises.

Real Challenges. Real Results.

A few examples of how the network handles real startup challenges.

Oncology, Phase II — Rapid Rescue Site Activation

Challenge: A global sponsor experienced poor enrollment and site dropout during a large-scale oncology trial across the US.

Identified and matched 2 high-performing oncology sites within 15 business days
Completed feasibility and document submissions
Negotiated contracts and budgets
Scheduled and completed PSVs

Rare Disease Study — Fast-Track Site Matching

Challenge: A CRO managing a rare disease study needed a site with an engaged, experienced PI in a specific region.

Matching site identified within 4 days
PI had direct rare disease experience and a clean audit history
Study materials submitted within one week

Rheumatology, Phase III — Multistate Site Activation

Challenge: A sponsor needed to activate multiple rheumatology sites across different US states, each with varying timelines.

4 geographically distributed, experienced sites and board-certified PIs identified
Rapid feasibility submission with streamlined approval
A single, customized budget structure across all sites

Psychiatry, Phase III — Single Point of Contact for 5 Sites

Challenge: A CRO needed to activate 5 geographically distributed sites, each with unique startup requirements — previously slowed by fragmented communication and inconsistent timelines.

All 5 sites submitted together in a single feasibility batch
FQ responses and site profiles consolidated centrally
PSV/SSV visits aligned through one dedicated project lead
Contract and budget negotiations handled centrally for fast CTA execution

Beyond the Contract: What Sponsors Notice

Extensive Site Network

A diverse network spanning multiple geographies and specialties — experienced, high-enrolling site teams for your study.

Regulatory Compliance

Sites adhere strictly to local and international regulatory requirements, with confidentiality safeguarded at every step.

Visit Coordination

PSVs and SSVs scheduled around your availability, with pre-visit documentation prepared before your team arrives.

Investigators Who Lead, Not Just Sign.

Our PIs are engaged leaders — actively involved in recruitment, safety oversight, protocol adherence, and team management.

NATIONWIDE COVERAGE

Your Trial, Supported Coast to Coast

Our footprint spans the United States — every site pre-vetted, equipped, staffed, and ready to enroll. The network is growing fast, adding new sites across every region.

Coverage Across Every Major Therapeutic Area

Rheumatology

Neurology

Oncology

Dermatology

Psychiatry

Respiratory

Cardiology

Endocrinology

Infectious Disease

Gastroenterology

Women’s Health

Much More

Common Questions from Sponsors

Who do we contract with?

BNZ is your single point of contact from sourcing through close-out, but budgets and contracts are negotiated individually with each participating site — not one blanket agreement across the network. You deal with one team; each site’s terms are its own.

How does BNZ maintain site accountability?

Every network site operates under a Site Collaboration Agreement with defined performance, compliance, and communication obligations — and a dedicated BNZ project lead oversees delivery end to end.

How quickly can feasibility be turned around?

Initial network feasibility typically returns within 24–48 hours, because we maintain current site profiles, PI availability, and capability data across the network.

Which therapeutic areas and phases do you cover?

The network spans all major therapeutic areas and Phase I–IV studies, with site matching driven by enrollment history, infrastructure, and PI expertise.

Ready to De-Risk Your Next Study Startup?

Let us show you how our sites and systems are built for speed — without compromising quality.

contact@bnzresearchnetwork.com